abstract |
The present invention relates to compositions and methods of treating and diagnosingndisorders characterized by the presence of antigens associated with inflammatoryndiseases and/or cancer, and nucleotide sequences, including expressed sequence tagsn(ESTs), oligonucleotide probes, polypeptides, vectors and host cells expressing suchnantigens PRO301, PRO362 or PRO245. |